Epilepsy Care in Developing Countries
Author Information
Author(s): Radhakrishnan Kurupath, R. Madhavan Nayar
Primary Institution: Sree Chitra Tirunal Institute for Medical Sciences and Technology
Hypothesis
How can the treatment gap for epilepsy in developing countries be minimized?
Conclusion
The high treatment gap in developing countries can be significantly reduced by increasing the availability of low-cost antiepileptic drugs and improving education about epilepsy management.
Supporting Evidence
- Nearly 80% of the global burden of epilepsy is borne by developing countries.
- A significant proportion of patients with epilepsy in these countries never receive appropriate treatment.
- Cost and cultural beliefs contribute to a high treatment gap in resource-poor countries.
- Education about epilepsy can help reduce stigma and improve treatment adherence.
- Only 13% of low-income countries have access to epilepsy surgery programs.
Takeaway
Many people with epilepsy in developing countries don't get the help they need because of costs and misunderstandings about the condition. We can help by making medicines cheaper and teaching people more about epilepsy.
Methodology
The study involved a review of the challenges faced in managing epilepsy in developing countries, including treatment gaps and social stigma.
Potential Biases
Potential biases may arise from the reliance on self-reported data regarding treatment adherence and stigma.
Limitations
The study primarily focuses on developing countries and may not fully represent the situation in developed nations.
Participant Demographics
The study discusses the general population of people with epilepsy in developing countries, particularly in India and China.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website